Cargando…

Lobaplatin Inhibits the Proliferation of Hepatollular Carcinoma Through P53 Apoptosis Axis

Detalles Bibliográficos
Autores principales:	Wang, Ying, Zheng, Wen-Ling, Ma, Wen-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500997/ https://www.ncbi.nlm.nih.gov/pubmed/23193415 http://dx.doi.org/10.5812/hepatmon.6024

Ejemplares similares

Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
por: Cao, Hongwen, et al.
Publicado: (2019)

Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
por: Zhang, Hongming, et al.
Publicado: (2019)

Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression
por: Tian, Wuguo, et al.
Publicado: (2018)

Lobaplatin promotes (125)I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway
por: Li, Dong, et al.
Publicado: (2019)

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial
por: Ke, Liang-Ru, et al.
Publicado: (2017)

Lobaplatin: Multiple toxicities: case report.
Publicado: (2020)

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
por: Wu, Qiong, et al.
Publicado: (2010)

Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study
por: Lu, Haohao, et al.
Publicado: (2023)

ZNF143 Suppresses Cell Apoptosis and Promotes Proliferation in Gastric Cancer via ROS/p53 Axis
por: Zhang, Yi, et al.
Publicado: (2020)

Downregulation of inhibitor of apoptosis-stimulating protein of p53 inhibits proliferation and promotes apoptosis of gastric cancer cells
por: WANG, LU-LU, et al.
Publicado: (2015)

Modulation of cyclins and p53 in mesangial cell proliferation and apoptosis during Habu nephritis
por: Lu, Yang, et al.
Publicado: (2015)

Inhibition of mycobacteria proliferation in macrophages by low cisplatin concentration through phosphorylated p53-related apoptosis pathway
por: Bao, Jiajia, et al.
Publicado: (2023)

Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma
por: Lu, Zhong-Wu, et al.
Publicado: (2020)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021)

Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo
por: Zhou, Zijun, et al.
Publicado: (2020)

miRNA-125a-5p inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting TP53 regulated inhibitor of apoptosis 1 and Bcl-2-like-2 protein
por: Ming, Ma, et al.
Publicado: (2019)

P53 protein in proliferation, repair and apoptosis of cells
por: Wawryk-Gawda, Ewelina, et al.
Publicado: (2013)

Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway
por: Zhu, Liying, et al.
Publicado: (2020)

Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.
por: Basolo, F., et al.
Publicado: (1997)

Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly
por: Cheng, Ying, et al.
Publicado: (2019)

LINC00313 promotes the proliferation and inhibits the apoptosis of chondrocytes via regulating miR-525-5p/GDF5 axis
por: He, Wen, et al.
Publicado: (2023)

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.
por: Gietema, J. A., et al.
Publicado: (1995)

Sesamin inhibits cervical cancer cell proliferation by promoting p53/PTEN-mediated apoptosis
por: Kuo, Tian-Ni, et al.
Publicado: (2020)

Downregulation of GBAS regulates oral squamous cell carcinoma proliferation and apoptosis via the p53 signaling pathway
por: Wang, Xing, et al.
Publicado: (2019)

Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression
por: Wu, Cuiping, et al.
Publicado: (2016)

FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma
por: Wang, Chaojia, et al.
Publicado: (2021)

Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
por: Zhang, Chao, et al.
Publicado: (2022)

The p53 control of apoptosis and proliferation: lessons from Drosophila
por: Mollereau, Bertrand, et al.
Publicado: (2014)

Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
por: Wang, Huan, et al.
Publicado: (2021)

Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
por: Yu, Junhui, et al.
Publicado: (2019)

APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis
por: Liao, Xiaolin, et al.
Publicado: (2018)

Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway
por: Yu, Qian, et al.
Publicado: (2023)

Apoptosis of mouse myeloma cells induced by curcumin via the Notch3-p53 signaling axis
por: Zhang, Ying, et al.
Publicado: (2019)

Human corticotrophin releasing factor inhibits cell proliferation and promotes apoptosis through upregulation of tumor protein p53 in human glioma
por: Feng, Yan, et al.
Publicado: (2018)

TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway
por: Chen, Liuyan, et al.
Publicado: (2022)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells
por: Pu, Qian, et al.
Publicado: (2020)

Retrospective study of the efficacy and toxicity of lobaplatin in combined chemotherapy for metastatic breast cancer
por: Wu, Yuan, et al.
Publicado: (2019)

Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
por: Li, Fenghu, et al.
Publicado: (2019)

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ut8jhokvi6lnq8hq3ecfd556fp